To investigate the clinical, hormonal, and genetic factors in infertile men with idiopathic nonobstructive azoospermia (NOA) or azoospermic Klinefelter syndrome (KFS), a total of 556 and 96 patients, respectively, were included in this study. All patient samples were analyzed cytogenetically. Serum reproductive hormone levels were measured. Microdeletions in the azoospermia factor (AZF) region of the Y chromosome were detected by multiplex PCR using 16 specific sequence-tagged sites. FSH and LH levels in both NOA and KFS patients were significantly higher than the normal range, and the testosterone level in KFS patients was significantly lower. Ninety-two (95.8%) of the KFS patients showed non-mosaic 47,XXY karyotypes and 47,XXY,inv(9)(p11.1q13); the other KFS patients had mosaic karyotypes of 47,XXY/46,XY, 47,XXY/46,XX, and 47,XXY/48,XXXY/46,XX. Among the 556 idiopathic NOA patients with normal karyotypes, 67 (12.05%) had microdeletions in the AZF region of the Y chromosome. Microdeletions were most frequently detected in the AZFc region, followed by AZFa, AZFb, AZFbc, and partial AZFc deletions. However, Y chromosome microdeletions were not found in any of the azoospermic KFS patients. In view of the hormonal and genetic abnormalities in infertile men with idiopathic NOA and with azoospermic KFS, genetic testing for karyotype, Y chromosome microdeletions, and hormonal parameters is advocated.

Keywords:
Y chromosome microdeletions, Idiopathic nonobstructive azoospermia, Karyotype, Klinefelter syndrome, Reproductive hormones
1.
Abdel-Razic MM, Abdel-Hamid IA, Elsobky E, El-Dahtory F: Further evidence of the clinical, hormonal, and genetic heterogeneity of Klinefelter syndrome: a study of 216 infertile Egyptian patients. J Androl 33:441-448 (2012).
2.
Anderson RA, Wallace EM, Groome NP, Bellis AJ, Wu FC: Physiological relationships between inhibin B, follicle stimulating hormone secretion and spermatogenesis in normal men and response to gonadotrophin suppression by exogenous testosterone. Hum Reprod 12:746-751 (1997).
3.
Babu SR, Sadhnani MD, Swarna M, Padmavathi P, Reddy PP: Evaluation of FSH, LH and testosterone levels in different subgroups of infertile males. Indian J Clin Biochem 19:45-49 (2004).
4.
Balkan M, Tekes S, Gedik A: Cytogenetic and Y chromosome microdeletion screening studies in infertile males with oligozoospermia and azoospermia in Southeast Turkey. J Assist Reprod Genet 25:559-565 (2008).
5.
Bar G, Lunenfeld E, Levitas E: Klinefelter syndrome: genetic aspects, characteristics and reproduction - present and future (in Hebrew). Harefuah 153:342-345 (2014).
6.
Behulova R, Varga I, Strhakova L, Bozikova A, Gabrikova D, et al: Incidence of microdeletions in the AZF region of the Y chromosome in Slovak patients with azoospermia. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 155:33-38 (2011).
7.
Bergmann M, Behre HM, Nieschlag E: Serum FSH and testicular morphology in male infertility. Clin Endocrinol (Oxf) 40:133-136 (1994).
8.
Chellat D, Rezgoune ML, McElreavey K, Kherouatou N, Benbouhadja S, et al: First study of microdeletions in the Y chromosome of Algerian infertile men with idiopathic oligo- or azoospermia. Urol Int 90:455-459 (2013).
9.
Choe JH, Kim JW, Lee JS, Seo JT: Routine screening for classical azoospermia factor deletions of the Y chromosome in azoospermic patients with Klinefelter syndrome. Asian J Androl 9:815-820 (2007).
10.
Choi DK, Gong IH, Hwang JH, Oh JJ, Hong JY: Detection of Y chromosome microdeletion is valuable in the treatment of patients with nonobstructive azoospermia and oligoasthenoteratozoospermia: sperm retrieval rate and birth rate. Korean J Urol 54:111-116 (2013).
11.
Edwards RG, Bishop CE: On the origin and frequency of Y chromosome deletions responsible for severe male infertility. Mol Hum Reprod 3:549-554 (1997).
12.
Foresta C, Ferlin A, Garolla A, Moro E, Pistorello M, et al: High frequency of well-defined Y-chromosome deletions in idiopathic Sertoli cell-only syndrome. Hum Reprod 13:302-307 (1998).
13.
Foresta C, Moro E, Ferlin A: Y chromosome microdeletions and alterations of spermatogenesis. Endocr Rev 22:226-239 (2001).
14.
Forti G, Corona G, Vignozzi L, Krausz C, Maggi M: Klinefelter's syndrome: a clinical and therapeutical update. Sex Dev 4:249-258 (2010).
15.
Ghorbel M, Gargouri Baklouti S, Ben Abdallah F, Zribi N, Cherif M, et al: Chromosomal defects in infertile men with poor semen quality. J Assist Reprod Genet 29:451-456 (2012).
16.
Gudeloglu A, Parekattil SJ: Update in the evaluation of the azoospermic male. Clinics (Sao Paulo) 68 Suppl 1:27-34 (2013).
17.
Huh JW, Kim WY, Kim DS, Ha HS, Lee JR, et al: Comparative analysis of Y chromosomal microdeletions in Korean infertile men of 47,XXY and 46,XY karyotypes. J Life Sci 17:741-747 (2007).
18.
Ishikawa T, Yamaguchi K, Kondo Y, Takenaka A, Fujisawa M: Metabolic syndrome in men with Klinefelter's syndrome. Urology 71:1109-1113 (2008).
19.
Jarvi K, Lo K, Fischer A, Grantmyre J, Zini A, et al: CUA Guideline: the workup of azoospermic males. Can Urol Assoc J 4:163-167 (2010).
20.
Kamischke A, Baumgardt A, Horst J, Nieschlag E: Clinical and diagnostic features of patients with suspected Klinefelter syndrome. J Androl 24:41-48 (2003).
21.
Kim SY, Kim HJ, Lee BY, Park SY, Lee HS, Seo JT: Y chromosome microdeletions in infertile men with non-obstructive azoospermia and severe oligozoospermia. J Reprod Infertil 18:307-315 (2017).
22.
Koşar PA, Ozçelik N, Koşar A: Cytogenetic abnormalities detected in patients with non-obstructive azoospermia and severe oligozoospermia. J Assist Reprod Genet 27:17-21 (2010).
23.
Krausz C, Degl'Innocenti S: Y chromosome and male infertility: update, 2006. Front Biosci 11:3049-3061 (2006).
24.
Lanfranco F, Kamischke A, Zitzmann M, Nieschlag E: Klinefelter's syndrome. Lancet 364:273-283 (2004).
25.
Lee JY, Dada R, Sabanegh E, Carpi A, Agarwal A: Role of genetics in azoospermia. Urology 77:598-601 (2011).
26.
Lee YH, Kim T, Kim MH, Kim YT, Kim SH: Y chromosome microdeletions in idiopathic azoospermia and non-mosaic type of Klinefelter syndrome. Exp Mol Med 32:231-234 (2000).
27.
Maduro MR, Lamb DJ: Understanding new genetics of male infertility. J Urol 168:2197-2205 (2002).
28.
Mirfakhraie R, Mirzajani F, Kalantar SM, Montazeri M, Salsabili N, et al: High prevalence of AZFb microdeletion in Iranian patients with idiopathic non-obstructive azoospermia. Indian J Med Res 132:265-270 (2010).
29.
Mitra A, Dada R, Kumar R, Gupta NP, Kucheria K, Gupta SK: Y chromosome microdeletions in azoospermic patients with Klinefelter's syndrome. Asian J Androl 8:81-88 (2006).
30.
Namiki M: Genetic aspects of male infertility. World J Surg 24:1176-1179 (2000).
31.
Nieschlag E: Klinefelter syndrome: the commonest form of hypogonadism, but often overlooked or untreated. Dtsch Arztebl Int 110:347-353 (2013).
32.
Pacenza N, Pasqualini T, Gottlieb S, Knoblovits P, Costanzo PR, et al: Clinical presentation of Klinefelter's syndrome: differences according to age. Int J Endocrinol 2012:324835 (2012).
33.
Peterlin B, Kunej T, Sinkovec J, Gligorievska N, Zorn B: Screening for Y chromosome microdeletions in 226 Slovenian subfertile men. Hum Reprod 17:17-24 (2002).
34.
Simoni M, Kamischke A, Nieschlag E: Current status of the molecular diagnosis of Y-chromosomal microdeletions in the work-up of male infertility. Initiative for international quality control. Hum Reprod 13:1764-1768 (1998).
35.
Tateno T, Sasagawa I, Ichiyanagi O, Ashida J, Nakada T, et al: Microdeletion of the DAZ (deleted in azoospermia) gene or the YRRM (Y chromosome ribonucleic acid recognition motif) gene does not occur in patients with Klinefelter's syndrome with and without spermatogenesis. Fertil Steril 71:746-749 (1999).
36.
Tincani BJ, Mascagni BR, Pinto RD, Guaragna-Filho G, Castro CC, et al: Klinefelter syndrome: an unusual diagnosis in pediatric patients. J Pediatr (Rio J) 88:323-327 (2012).
37.
Tu W, Liu Y, Shen Y, Yan Y, Wang X, et al: Genome-wide loci linked to non-obstructive azoospermia susceptibility may be independent of reduced sperm production in males with normozoospermia. Biol Reprod 92:41 (2015).
38.
Tüttelmann F, Rajpert-De Meyts E, Nieschlag E, Simoni M: Gene polymorphisms and male infertility - a meta-analysis and literature review. Reprod Biomed Online 15:643-658 (2007).
39.
Visootsak J, Graham JM Jr: Klinefelter syndrome and other sex chromosomal aneuploidies. Orphanet J Rare Dis 1:42 (2006).
40.
Vogt PH, Edelmann A, Kirsch S, Henegariu O, Hirschmann P, et al: Human Y chromosome azoospermia factors (AZF) mapped to different subregions in Yq11. Hum Mol Genet 5:933-943 (1996).
41.
Wettasinghe TK, Jayasekara RW, Dissanayake VH: The low frequency of Y chromosome microdeletions in subfertile males in a Sinhalese population of Sri Lanka. Indian J Hum Genet 18:320-325 (2012).
42.
World Health Organization: WHO Laboratory Manual for the Examination and Processing of Human Semen, ed 5 (WHO Press, Geneva 2010).
43.
Yen PH: Putative biological functions of the DAZ family. Int J Androl 27:125-129 (2004).
© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.